Free Trial

Pekin Hardy Strauss Inc. Makes New Investment in Healthcare Realty Trust Incorporated (NYSE:HR)

Healthcare Realty Trust logo with Finance background

Pekin Hardy Strauss Inc. acquired a new position in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 21,000 shares of the real estate investment trust's stock, valued at approximately $355,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HR. Golden State Wealth Management LLC bought a new position in Healthcare Realty Trust during the first quarter worth about $26,000. Smartleaf Asset Management LLC boosted its holdings in Healthcare Realty Trust by 59.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock worth $27,000 after buying an additional 612 shares during the last quarter. Lazard Asset Management LLC bought a new position in Healthcare Realty Trust during the fourth quarter worth about $45,000. UMB Bank n.a. lifted its holdings in shares of Healthcare Realty Trust by 73.3% during the 1st quarter. UMB Bank n.a. now owns 3,024 shares of the real estate investment trust's stock valued at $51,000 after purchasing an additional 1,279 shares in the last quarter. Finally, Jones Financial Companies Lllp lifted its holdings in shares of Healthcare Realty Trust by 68.7% during the 4th quarter. Jones Financial Companies Lllp now owns 3,067 shares of the real estate investment trust's stock valued at $52,000 after purchasing an additional 1,249 shares in the last quarter.

Analysts Set New Price Targets

Several research firms have recently weighed in on HR. Wedbush cut their price objective on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a report on Monday, May 5th. JPMorgan Chase & Co. cut their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a report on Thursday, June 26th. Wall Street Zen cut Healthcare Realty Trust from a "hold" rating to a "sell" rating in a report on Saturday, May 31st. Finally, Wells Fargo & Company cut their price objective on Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating on the stock in a report on Monday, June 2nd. Two investment analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $16.40.

View Our Latest Research Report on Healthcare Realty Trust

Insider Buying and Selling at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian purchased 2,500 shares of the stock in a transaction on Tuesday, May 13th. The shares were purchased at an average price of $14.71 per share, with a total value of $36,775.00. Following the transaction, the director directly owned 56,502 shares of the company's stock, valued at $831,144.42. This trade represents a 4.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.37% of the stock is owned by company insiders.

Healthcare Realty Trust Stock Performance

Healthcare Realty Trust stock traded up $0.22 during midday trading on Wednesday, reaching $16.12. The stock had a trading volume of 3,391,181 shares, compared to its average volume of 3,152,690. The firm's fifty day simple moving average is $15.04 and its 200-day simple moving average is $15.95. Healthcare Realty Trust Incorporated has a 1-year low of $14.09 and a 1-year high of $18.90. The stock has a market capitalization of $5.66 billion, a P/E ratio of -14.79 and a beta of 0.89.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last announced its earnings results on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.39. The business had revenue of $288.86 million for the quarter, compared to analyst estimates of $297.39 million. Healthcare Realty Trust had a negative return on equity of 7.06% and a negative net margin of 31.32%. Healthcare Realty Trust's revenue for the quarter was down 9.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.39 EPS. On average, sell-side analysts anticipate that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current fiscal year.

Healthcare Realty Trust Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 23rd. Shareholders of record on Monday, May 12th were given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 7.69%. The ex-dividend date of this dividend was Monday, May 12th. Healthcare Realty Trust's dividend payout ratio (DPR) is -113.76%.

About Healthcare Realty Trust

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Featured Articles

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines